Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 60Sarcoma 3Gynecologic 3Genitourinary 2CNS 2Head & Neck 1Endocrine 1Breast 1

Conditions

Neuroblastoma 5Colonic Neoplasms 5Pancreatic Neoplasms 3Osteosarcoma 3Melanoma 3Medulloblastoma 3Glioblastoma 3Familial ependymoma 3Stomach Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Optic Nerve Glioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Multiple Myeloma 2Gallbladder Neoplasms 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Astrocytoma 2Wilms Tumor 1Vipoma 1Thyroid Neoplasms 1Testicular Neoplasms 1Teratoma 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1

Interventions

Nivolumab 4Magnetic Resonance Spectroscopy 4fludarabine 3Fluorodeoxyglucose F18 3Cyclophosphamide 3Cisplatin 3ulixertinib 2sargramostim 2X-Rays 2Trastuzumab 2Sunitinib 2Stem Cell Transplantation 2Specimen Handling 2Sirolimus 2Oxaliplatin 2Melphalan 2Leucovorin 2FAPI-46 2Erlotinib Hydrochloride 2Cryosurgery 2Crizotinib 2Capecitabine 2Busulfan 2Bevacizumab 2trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sapanisertib 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Oxaliplatin × CNS × Clear all
NCT05919264 2026-05-12

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Parabilis Medicines, Inc.

Phase 1/2 Recruiting
595 enrolled
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT00005860 2011-04-26

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

National Cancer Institute (NCI)

Phase 1 Completed
CNSEndocrineGastrointestinalGynecologicSarcoma

Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Fallopian Tube Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Neoplasms, Neoplasms, Unknown Primary, Neuroblastoma, Pancreatic Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Stomach Neoplasms, Gastrinoma, Carcinoma, Islet Cell, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡